In Situ Photo‑Crosslinked Functional Bilayer Hydrogel Modulates Local Microenvironment and Remyelination After Optic Nerve Injury.

Authors

Tonghe Pan, Yate Huang, Junhao Zhang, Shudong Tian, Zhixing Li, Xuanwen Li, Yanchen Zhang, Dongmei Wang, Sihao Ye, Ming Jin, Neng Ling, Wentao Yan, Kaihui Nan, Wencan Wu

Published in

Advanced science (Weinheim, Baden-Wurttemberg, Germany). Pages e78031. Sep 27, 2026. Epub Sep 27, 2026.

Abstract

Optic nerve injury often causes irreversible vision loss due to limited self-regeneration capacity, persistent neuroinflammation, and failed remyelination. Current therapies partially promote axonal regeneration but rarely achieve meaningful visual recovery, limited mainly by unstable myelin reconstruction and inadequate injury microenvironment modulation. Here, we developed a photo-crosslinkable bilayer hydrogel system (GO/GI@MPDA-Cle). Its outer layer (GM-Odex) provides strong wet tissue adhesion for optic nerve sheath sealing, while the inner layer (GM-imid) enables sustained local release of drug-loaded nanoparticles (MPDA-Cle) for microenvironment modulation. In Vitro, the system exhibited excellent antioxidant and anti-inflammatory properties and polarized microglia toward an anti‑inflammatory phenotype. In a rat partial optic nerve injury model, the hydrogel protected retinal ganglion cells through local immunomodulation and was associated with improved oligodendrocyte-associated maturation and remyelination-associated repair, accompanied by partial improvement in optic nerve conduction-related function. Transcriptomic analysis further revealed that the treatment downregulated pathways related to inflammation, oxidative stress, and neuronal apoptosis, while upregulating genes involved in neuronal regeneration, axonal growth, and myelination. By integrating physical sealing, immunomodulation, and myelin repair, this study proposes a promising multifunctional strategy for optic nerve injury treatment.

PMID:
42801552
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.